NCT04626960View on ClinicalTrials.gov

ADRB3, ROCK2 and GEF Levels in Overactive Bladder Patients

CompletedOBSERVATIONAL

Enrollment

120

Participants

Timeline

Start Date

June 5, 2019

Primary Completion Date

December 12, 2019

Study Completion Date

June 7, 2020

Conditions

Overactive Bladder

Trial Locations (1)

Unknown

Pamukkale University, Denizli

All Listed Sponsors

lead

Pamukkale University

OTHER

NCT04626960 - ADRB3, ROCK2 and GEF Levels in Overactive Bladder Patients | Biotech Hunter | Biotech Hunter